Search Within

Department of Medicine

Formats
  1. Journal Article (19567)
  2. Meeting Abstract (16038)
  3. Review (1147)
  4. Book Section (934)
  5. Editorial (607)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (235)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22308)
  2. Hematologic Malignancies, Division of (13262)
  3. Center for Hematologic Malignancies (11047)
  4. GSK Faculty (10638)
  5. Survivorship Research (9321)
  6. Division of Subspecialty Medicine (7530)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1068)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1038)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3721)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6456)
  2. Elsevier Inc. (4212)
  3. American Society of Hematology (4000)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2109)

More Publishers

Results (39589)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1/2 study of high-dose palifermin for GVHD prophylaxis in patients undergoing HLA-matched unrelated donor HCT
    Journal Article

    Schulz, E.; Curtis, L. M.; Holtzman, N. G.; Steinberg, S. M.; Wloka, K.; Ostojic, A.; Mina, A.; El Jurdi, N.; Pirsl, F.; Carpenter, A.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • T-ICAHT: Grading and prognostic impact of thrombocytopenia after CAR T-cell therapy
    Journal Article

    Rejeski, K.; Sanz, J.; Fei, T.; Nair, M. S.; Hashmi, H.; Avigdor, A.; Beyar-Katz, O.; Bücklein, V. L.; Curran, K. J.; Einarsdottir, S.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • The Dublin International Society of Urological Pathology (ISUP) consensus conference on best practice recommendations on the pathology of urachal neoplasms
    Guidelines

    Reis, H.; Al-Ahmadie, H.; Gaisa, N. T.; Lopez-Beltran, A.; Maclean, F.; Tsuzuki, T.; Werneck da Cunha, I.; Amin, M. B.; Aning, J.; Aron, M.; more...
    American Journal of Surgical Pathology (2025)

    Fulltext@MSK | Save
  • Electrolytes abnormalities in cancer patients
    Review

    Rashidi, A.; Youssef, N.; Workeneh, B.; Carsel, A.; Gutgarts, V.; Latcha, S.
    American Journal of Nephrology (2025)

    Fulltext@MSK | Save
  • Health-related quality of life, pain, and symptomatic skeletal events with [(177)Lu]Lu-PSMA-617 in patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): An open-label, randomised, phase 3 trial
    Journal Article

    Fizazi, K.; Morris, M. J.; Shore, N.; Chi, K. N.; Crosby, M.; de Bono, J. S.; Herrmann, K.; Roubaud, G.; Nagarajah, J.; Fleming, M.; more...
    Lancet Oncology (2025)

    Fulltext@MSK | Save
  • Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: Primary results of a multicentre, single-arm, phase 2 study
    Journal Article

    Elimova, E.; Ajani, J.; Burris, H.; Denlinger, C. S.; Iqbal, S.; Kang, Y. K.; Kim, J. H.; Lee, K. W.; Lin, B.; Mehta, R.; more...
    Lancet Oncology (2025)

    Fulltext@MSK | Save
  • Management of osilodrostat therapy in patients with Cushing's syndrome: A modified Delphi consensus panel
    Journal Article

    Samson, S. L.; Donegan, D.; Geer, E. B.; Gordon, M. B.; Hamidi, O.; Huang, W.; Ioachimescu, A. G.; Silverstein, J. M.; Spencer-Segal, J. L.; Tritos, N. A.; more...
    Journal of the Endocrine Society (2025)

    Fulltext@MSK | Save
  • Phase III trial of pirtobrutinib versus idelalisib/rituximab or bendamustine/rituximab in covalent Bruton tyrosine kinase inhibitor-pretreated chronic lymphocytic leukemia/small lymphocytic lymphoma (BRUIN CLL-321)
    Journal Article

    Sharman, J. P.; Munir, T.; Grosicki, S.; Roeker, L. E.; Burke, J. M.; Chen, C. I.; Grzasko, N.; Follows, G.; Mátrai, Z.; Sanna, A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab and chemotherapy versus chemotherapy in advanced metastatic gastroesophageal adenocarcinoma: The phase III, randomized LEAP-015 study
    Journal Article

    Shitara, K.; Lorenzen, S.; Li, J.; Bai, Y. X.; Fernández, M. G.; Aguilar, M.; Shoji, H.; Reyes-Cosmelli, F.; Peña, Y. R.; Corrales, L.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Zipalertinib in patients with epidermal growth factor receptor exon 20 insertion-positive non-small cell lung cancer previously treated with platinum-based chemotherapy with or without amivantamab
    Journal Article

    Piotrowska, Z.; Passaro, A.; Nguyen, D.; Ruiter, G.; Soo, R. A.; Lee, V. H. F.; Velcheti, V.; Tan, D. S. W.; Lee, S. H.; Kim, S. H.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save